AI Agentic Workflow for Continuous R&D Signal Monitoring

Manual processes rely on scientists remembering to file disclosures, often weeks or months after a breakthrough. A continuous monitoring workflow, built with agents parsing lab notebooks, Git commits, and collaboration tools (e.g., Confluence, Slack), flags novel concepts in real-time. This compresses the initial capture cycle from an average of 4-6 weeks to days, preventing valuable IP from being lost to internal publication or competitor filings.

Without systematic scanning, significant inventions buried in years of research PDFs, presentation decks, and code comments are never identified for patenting. A custom workflow using LLM-powered document understanding and vector search (e.g., via LangChain) mines these unstructured repositories. It surfaces latent IP and cross-references internal publications against external patent databases to flag prior art risks created by your own teams, protecting your freedom to operate.

The labor cost of manual invention harvesting—chasing scientists, conducting interviews, drafting initial disclosures—is substantial. Automating signal capture and initial triage with a multi-agent system reallocates high-cost legal and IP staff time to strategic review and prosecution. The architecture uses orchestration frameworks (e.g., LangGraph) to route flagged concepts to the correct domain expert, slashing administrative overhead per viable invention.

Linking automated IP discovery directly to Product Lifecycle Management (PLM) or Application Lifecycle Management (ALM) systems like Siemens Teamcenter or Jira creates a closed-loop. The workflow tags potential inventions to specific projects and components, providing clear data on which R&D investments yield the highest IP yield. This enables data-driven portfolio strategy and justifies continued R&D spend with tangible asset creation.

A reactive IP process discovers prior art problems late in development or during litigation. Continuous monitoring includes an automated internal prior art scan, comparing new R&D signals against your own historical patent filings and publications. This workflow, integrated with docketing systems like Anaqua, provides an early warning system, allowing for design-arounds or defensive publications before a competitor files, reducing future litigation exposure and costs.

Fragmented invention data delays global filing decisions and increases the risk of missing critical PCT or national phase deadlines. A custom workflow centralizes all captured signals, novelty assessments, and draft materials, feeding them directly into Enterprise Legal Management (ELM) systems like Onit or Mitratech. This creates a single source of truth, enabling faster decisions on filing jurisdictions and automating docketing for seamless global portfolio management.

This foundational agent orchestrates secure, continuous data pulls from fragmented internal sources: Git repositories (code commits, comments), ELNs/LIMS (structured experiment data), collaboration tools (Slack, Teams channels), and document stores (PDFs, presentations, lab notebooks). It uses LLM-powered extraction to identify novel technical concepts, chemical structures, algorithms, or design features, converting unstructured text into structured innovation signals for downstream analysis. Implementation integrates with APIs and, where necessary, secure RPA for legacy systems without modern interfaces.

This agent receives parsed signals and performs a two-tier novelty assessment. First, it queries internal historical disclosures and prior internal publications via a vector database to check for self-prior-art. Second, it orchestrates live API calls to external patent databases (USPTO, EPO, WIPO) and scientific literature (PubMed, arXiv) using hybrid keyword and semantic search. It generates a novelty score and confidence level based on claim similarity, publishing a structured evidence packet to a review queue. The architecture is built on retrieval-augmented generation (RAG) pipelines with reranking for precision.

The central workflow engine that applies business logic to scored signals. It routes high-confidence, high-strategic-value inventions to the appropriate domain expert (e.g., semiconductor designs to the chip IP lead, biotech sequences to the life sciences attorney). For medium-confidence signals, it can trigger automated requests for additional data from the inventor via a chatbot interface. It manages approval gates, SLAs, and ensures no signal stalls, integrating directly with docketing systems (Anaqua, CPA Global) or legal matter management platforms to create a preliminary matter.

This agent creates a bi-directional link between the IP workflow and Product Lifecycle Management (PLM, e.g., Siemens Teamcenter) or Application Lifecycle Management (ALM, e.g., Jira) systems. It tags potential inventions to specific product components, features, or R&D projects. Conversely, it can be triggered by milestone completions in the PLM (e.g., 'Design Freeze') to initiate a focused IP scan of associated documentation. This embeds IP strategy directly into the development lifecycle, ensuring protection aligns with commercial roadmaps.

Not an agent, but a critical control plane component. This is the interface where IP committees, R&D managers, and attorneys review flagged signals, evidence packets, and novelty scores. It supports collaborative decision-making (Accept/Reject/Request Info), records rationale for audit trails, and allows for manual override of agent recommendations. The dashboard provides portfolio-level analytics on signal volume, domains, and harvest rate, turning the workflow's output into strategic business intelligence for R&D investment decisions.

A cross-cutting component that monitors the health, performance, and bias of the entire agentic system. It tracks ingestion pipeline failures, measures the precision/recall of the novelty scoring agent, and logs all agent decisions with explanations for regulatory and internal audit readiness. This layer enables continuous retraining of models based on reviewer feedback (e.g., which false positives were rejected) and ensures the workflow operates within defined governance guardrails, preventing uncontrolled automation of high-stakes IP decisions.